• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病患者血液中天然和修饰的低密度脂蛋白的化学成分特征分析。

Characterization of chemical composition of native and modified low density lipoprotein occurring in the blood of diabetic patients.

作者信息

Sobenin I A, Tertov V V, Orekhov A N

机构信息

Institute of Experimental Cardiology, Russian Academy of Medical Sciences, Moscow.

出版信息

Int Angiol. 1994 Mar;13(1):78-83.

PMID:8077803
Abstract

Low density lipoprotein (LDL) from Type 1 and Type 2 diabetic patients, unlike LDL from healthy subjects, caused a 1.5- to 2.5-fold increase in the cholesterol content of cells cultured from unaffected human aortic intima, i.e. possessed atherogenic potential. LDL were further divided into two subfractions by affinity chromatography on Ricinus communis agglutinin-agarose. The amount of bound LDL was significantly higher in diabetic patients as compared with healthy subjects. Bound LDLs differed from unbound ones by significantly lowered sialic acid content, i.e. were desialylated lipoproteins. Desialylated, but not sialylated LDL subfraction induced massive cholesterol accumulation in cultured cells. Desialylated LDL subfraction in diabetic patients was also characterized by a higher degree of nonenzymatic glycation as compared to LDL subfraction with normal sialic acid level. Desialylated LDL had significantly decreased levels of free and esterified cholesterol, triglycerides and phosphatidylcholine and elevated amounts of lysophosphatidylcholine. These disturbances in lipid constituent of LDL were weak in healthy subjects, but conspicuous in diabetic patients. The results of this study have shown that there is in vivo modified LDL subfraction in the blood of diabetic patients which is characterized by crucial changes in protein and lipid moiety and are able to induce massive cholesterol accumulation in cultured cells.

摘要

与健康受试者的低密度脂蛋白(LDL)不同,1型和2型糖尿病患者的LDL可使从未受影响的人主动脉内膜培养的细胞中的胆固醇含量增加1.5至2.5倍,即具有致动脉粥样硬化潜力。通过蓖麻凝集素-琼脂糖亲和层析将LDL进一步分为两个亚组分。与健康受试者相比,糖尿病患者中结合的LDL量明显更高。结合的LDL与未结合的LDL不同,其唾液酸含量显著降低,即去唾液酸化脂蛋白。去唾液酸化而非唾液酸化的LDL亚组分在培养细胞中诱导大量胆固醇积累。与唾液酸水平正常的LDL亚组分相比,糖尿病患者中的去唾液酸化LDL亚组分还具有更高程度的非酶糖基化特征。去唾液酸化LDL的游离胆固醇、酯化胆固醇、甘油三酯和磷脂酰胆碱水平显著降低,溶血磷脂酰胆碱含量升高。LDL脂质成分的这些紊乱在健康受试者中较弱,但在糖尿病患者中明显。本研究结果表明,糖尿病患者血液中存在体内修饰的LDL亚组分,其特征是蛋白质和脂质部分发生关键变化,并且能够在培养细胞中诱导大量胆固醇积累。

相似文献

1
Characterization of chemical composition of native and modified low density lipoprotein occurring in the blood of diabetic patients.糖尿病患者血液中天然和修饰的低密度脂蛋白的化学成分特征分析。
Int Angiol. 1994 Mar;13(1):78-83.
2
Multiple-modified desialylated low density lipoproteins that cause intracellular lipid accumulation. Isolation, fractionation and characterization.导致细胞内脂质蓄积的多种修饰去唾液酸低密度脂蛋白。分离、分级分离及特性鉴定。
Lab Invest. 1992 Nov;67(5):665-75.
3
Characterization of desialylated low-density lipoproteins which cause intracellular lipid accumulation.导致细胞内脂质蓄积的去唾液酸低密度脂蛋白的特性分析
Int J Tissue React. 1992;14(4):155-62.
4
Naturally occurring modified low density lipoproteins are similar if not identical: more electronegative and desialylated lipoprotein subfractions.天然存在的修饰低密度脂蛋白即便不完全相同也很相似:即更多的带负电和去唾液酸化的脂蛋白亚组分。
Exp Mol Pathol. 1995 Jun;62(3):166-72. doi: 10.1006/exmp.1995.1018.
5
Modified low density lipoprotein from diabetic patients causes cholesterol accumulation in human intimal aortic cells.糖尿病患者的修饰低密度脂蛋白会导致人主动脉内膜细胞中胆固醇积聚。
Atherosclerosis. 1993 Apr;100(1):41-54. doi: 10.1016/0021-9150(93)90066-4.
6
[Isolation of desialylated low density lipoproteins from the blood of patients with ischemic heart disease by affinity chromatography].[通过亲和色谱法从缺血性心脏病患者血液中分离去唾液酸低密度脂蛋白]
Biull Eksp Biol Med. 1990 Dec;110(12):606-9.
7
[Desialylated low density lipoproteins--atherogenic lipoproteins occurring in blood of patients with coronary atherosclerosis].[去唾液酸低密度脂蛋白——存在于冠状动脉粥样硬化患者血液中的致动脉粥样硬化脂蛋白]
Biull Eksp Biol Med. 1990 Aug;110(8):138-40.
8
Atherogenic modified LDL in diabetes.
Diabetes. 1996 Jul;45 Suppl 3:S35-9. doi: 10.2337/diab.45.3.s35.
9
[Carbohydrate composition of native and desialylated low density lipoproteins in the plasma of patients with coronary atherosclerosis].[冠状动脉粥样硬化患者血浆中天然及去唾液酸低密度脂蛋白的碳水化合物组成]
Kardiologiia. 1992 Sep;32(9-10):57-61.
10
Autoantibodies against low-density lipoprotein and atherogenic potential of blood.抗低密度脂蛋白自身抗体与血液的致动脉粥样硬化潜能
Ann Med. 1993 Dec;25(6):551-5.

引用本文的文献

1
Obstructive Sleep Apnoea and Lipid Metabolism: The Summary of Evidence and Future Perspectives in the Pathophysiology of OSA-Associated Dyslipidaemia.阻塞性睡眠呼吸暂停与脂质代谢:阻塞性睡眠呼吸暂停相关血脂异常病理生理学的证据总结与未来展望
Biomedicines. 2022 Oct 29;10(11):2754. doi: 10.3390/biomedicines10112754.
2
Modified low density lipoprotein and lipoprotein-containing circulating immune complexes as diagnostic and prognostic biomarkers of atherosclerosis and type 1 diabetes macrovascular disease.修饰的低密度脂蛋白和含脂蛋白的循环免疫复合物作为动脉粥样硬化和1型糖尿病大血管疾病的诊断和预后生物标志物。
Int J Mol Sci. 2014 Jul 21;15(7):12807-41. doi: 10.3390/ijms150712807.